Patent ID: 8067399

Claim:
A method for treating hypoactive sexual desire disorder (HSDD) or female sexual dysfunction (FSD) in a female in need thereof, which method comprises the daily and precise administering to a female of between 200 to 240 mg of a formulation that includes about 1% testosterone, an alkanol in an amount between about 5 to 80%, a polyalcohol in an amount between about 1% to 30%, and a permeation enhancer in an amount between about 1 to 30% with the formulation being substantially free of long-chain fatty alcohol, long-chain fatty acid and long-chain fatty ester compounds in order to accurately deliver between 2 to 2.4 mg of testosterone to achieve decreases in or alleviation of at least one of the clinical symptoms of HSDD or FSD in the female and to avoid irritation from such compounds during use of the formulation.